Since 2019, sweeping changes—from natural disasters and a pandemic—have tested pharmaceutical distribution and revealed the resilience of health care supply chain management. As the pharmaceutical supply chain evolves with advanced therapies and shifting regulations, distributors play a vital role, providing 96% of US medicine access. Their continued leadership drives innovation, regulatory compliance, and access across diverse patient care environments. Learn why distributors are now more valuable than ever.
The following four takeaways highlight the increasing value, demonstrated resilience, and evolving role of distributors within the industry.
Pharmaceutical distributors continue to play a central, steady role in supporting the industry’s supply chain through vital yet often low-margin core services like product transport, inventory management, and safeguarding supply chain reliability. While these foundational responsibilities remain unchanged, new developments and additional services are shaping the landscape.
Current core distribution services:
What’s shaping the landscape:
Pharmaceutical distributors are driving transformation by turning data into actionable insights, forging strategic alliances, and advancing patient access to therapies. Through innovation—including AI-driven solutions—they’re reshaping how care is delivered, setting the stage for a more connected future. Explore the full paper for in-depth examples and emerging trends.